Abertay Research Collections >
Research Centres >
SIMBIOS Collection >
Please use this identifier to cite or link to this item:
|Title: ||Systems pathology—taking molecular pathology into a new dimension|
|Authors: ||Faratian, Dana|
Clyde, Robert G.
Crawford, John W.
Harrison, David J.
|Affiliation: ||University of Abertay Dundee. Scottish Informatics, Mathematics, Biology and Statistics Centre|
|Keywords: ||Pathology, Molecular|
|Issue Date: ||Aug-2009|
|Publisher: ||Nature Publishing Group|
|Type: ||Journal Article|
|Rights: ||Published version (c)Nature Publishing Group, available from DOI: 10.1038/nrclinonc.2009.102|
|Citation: ||Faratian, D., et al. 2009. Systems pathology—taking molecular pathology into a new dimension. Nature Reviews Clinical Oncology. 6(8): pp.455-464. Available from DOI: 10.1038/nrclinonc.2009.102|
|Abstract: ||The wealth of morphological, histological, and molecular data from human cancers available to pathologists means that pathology is poised to become a truly quantitative systems science. By measuring morphological parameters such as tumor stage and grade, and by measuring molecular biomarkers such as hormone receptor status, pathologists have sometimes accurately predicted what will happen to a patient's tumor. While 'omic' technologies have seemingly improved prognostication and prediction, some molecular 'signatures' are not useful in clinical practice because of the failure to independently validate these approaches. Many associations between gene 'signatures' and clinical response are correlative rather than mechanistic, and such associations are poor predictors of how cellular biochemical networks will behave in perturbed, diseased cells. Using systems biology, the dynamics of reactions in cells and the behavior between cells can be integrated into models of cancer. The challenge is how to integrate multiple data from the clinic into tractable models using mathematical models and systems biology, and how to make the resultant model sufficiently robust to be of practical use. We discuss the difficulties in using mathematics to model cancer, and review some approaches that may be used to allow systems biology to be successfully applied in the clinic.|
|Appears in Collections:||SIMBIOS Collection|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.